Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Marimed (MRMD) over the last 7 years, with Q3 2025 value amounting to 0.03%.

  • Marimed's Return on Invested Capital fell 900.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.13% for FY2024, which is 3300.0% down from last year.
  • Per Marimed's latest filing, its Return on Invested Capital stood at 0.03% for Q3 2025, which was down 900.0% from 0.02% recorded in Q2 2025.
  • Over the past 5 years, Marimed's Return on Invested Capital peaked at 1.75% during Q1 2021, and registered a low of 0.03% during Q3 2023.
  • Over the past 5 years, Marimed's median Return on Invested Capital value was 0.15% (recorded in 2024), while the average stood at 0.32%.
  • As far as peak fluctuations go, Marimed's Return on Invested Capital plummeted by -444900bps in 2021, and later surged by 1800bps in 2024.
  • Quarter analysis of 5 years shows Marimed's Return on Invested Capital stood at 0.24% in 2021, then dropped by -9bps to 0.22% in 2022, then skyrocketed by 74bps to 0.38% in 2023, then plummeted by -60bps to 0.15% in 2024, then crashed by -78bps to 0.03% in 2025.
  • Its Return on Invested Capital stands at 0.03% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.